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Abstract
The aim. To evaluate the effectiveness of X-ray interventions in arosive bleeding in patients with complicated duodenal ulcer.
Materials and methods. X-ray endovascular interventions were used in 8 patients who developed arosive bleeding as 
a complication of duodenal ulcer. All patients with signs of gastrointestinal bleeding were examined according to clinical protocols. 
Hemodynamically stable patients underwent X-ray endovascular interventions.
Results and discussion. In the near future, bleeding stopped in all 8 (100 %, OR–0.04 [0.005–0.29], p = 0.03) patients. On day 2, 
two patients who underwent embolization of their own hepatic artery had a recurrence of bleeding (0.56 [0.065–4.76], p = 0.29). 
Repeated angiography and embolization attempts were ineffective, and both patients died. In patients who underwent gastroduodenal 
and pancreatouodenal artery embolization, bleeding did not resume. Thus, we obtained good results as 6 out of 8 patients recove-
red (75 %), despite the severity of their condition and a disappointing prognosis (OR–9.0 [1.0–46.7], p < 0.05).
Conclusions. Adherence to the tactics mentioned above in the treatment of bleeding in duodenal ulcer was highly effective, 
especially in superselective embolization with the detection of bleeding gel. If the presence of arosive bleeding is confirmed, emer-
gency surgical treatment with suturing of the damaged vessel is shown in hemodynamically unstable patients, and endovascular 
intervention is possible in hemodynamically stable patients. Further studies are needed to determine the criteria for a high risk 
of arosive bleeding developing in patients with complicated duodenal ulcer as well as to prevent its occurrence through the use of 
X-ray endovascular interventions. 
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1. Introduction
The prevalence of duodenal ulcer among the general population is 5–10 %; the disease is 
verified with a frequency of 0.1–0.3 % per year. The disease is more common in men, the ratio of 
men to women ranges from 2:1 to 10:1 [1, 2]. 
Complications of peptic ulcer disease, such as perforation and bleeding, have a significant 
economic impact. The total cost of peptic ulcer treatment in the United States, which includes both 
direct costs and loss of productivity, is estimated at $ 5.65 billion per year [3]. Acute bleeding from the 




upper gastrointestinal tract accounts for > 400,000 hospitalizations per year in the United States [4]. 
According to other statistical studies, in the European Union, the cost of bleeding, perforation or 
a combination of them per person is 12,000, 19,000 and 26,000 euros per patient respectively [5].
Bleeding from the upper gastrointestinal tract is the most common and unfavorable com-
plication of duodenal ulcer, which is 31 %–67 % of all cases of gastrointestinal bleeding [1, 6]. 
This condition, which requires immediate medical intervention, is accompanied by a high mor-
tality rate (up to 10 %) [7]. However, according to other studies, over the past few decades, the 
mortality rate, depending on the quality of care, has decreased to 3.5–7.4 % [8].
Helicobacter pylori infection, non-steroidal anti-inflammatory drugs and aspirin are con-
sidered to be the main risk factors for gastrointestinal bleeding [7, 9]. The risk of mortality, ac-
cording to the recommendations of the American Society of Anesthesiologists, is associated with 
the following features: hemoglobin < 70.0 g/l, age > 80 years, renal failure, bleeding due to failed 
endoscopic intervention. Moreover, the failure rate during medical endoscopy immediately after 
the intervention reaches 10 %, within 24–72 hours – 20 % [8, 10].
A number of methods can be used to stop and prevent further bleeding, including conser-
vative therapy, endoscopic, injection (adrenaline), thermoablative (coagulation probes) and mecha-
nical methods [11].
Thermal and mechanical methods of hemostasis are the most effective [12]. In addition, 
dual therapy, for example, mechanical hemostasis with endoclips, remains the optimal endoscopic 
therapy, according to the latest recommendations [13]. Despite the fact that a variety of endoscopic 
clips are available today, there is no evidence of a clear advantage of any type [14].
The next method, which is used in case of unsuccessful endoscopic hemostasis, is open 
surgery; however, the mortality rate in this case can reach 40 %. Trans-catheter arterial emboli-
zation (TAE) may be suggested as an alternative to surgery in groups of patients with recurrent 
bleeding, high-risk groups, and if endoscopic hemostasis has not been successful [15]. The effec-
tiveness of endoscopic ultrasonography under the control of angiotherapy has been considered in 
a number of small studies. Angiotherapy is effective in patients with lesions in which insufficient 
efficacy has been obtained with typical endoscopic methods [16].
The number of patients undergoing surgery for bleeding has decreased sharply with the 
introduction into widespread clinical practice in the treatment of bleeding in peptic ulcer of the 
stomach and duodenum, endoscopic methods of hemostasis, proton pump inhibitors and antibi-
otics. However, despite significant changes in the treatment tactics of gastrointestinal bleeding 
of ulcerative origin in the last 50 years, mortality has not changed significantly (6–13 %) [17].
Endoscopy does not reveal the source in approximately 20 % of cases of bleeding from the 
upper digestive tract. The most common is bleeding from an ulcer or from varicose veins of the 
esophagus and stomach [18].
Thus, the choice of diagnosis and the optimal method of treatment for bleeding duodenal 
ulcers remains an open problem of emergency surgery. Factors such as endoscopist’s skill, hemo-
dynamic instability, poor sedation, poor visualization, and difficult reach can affect the level of 
complications. In addition, factors that may affect the failure of endoscopic hemostasis include: 
large ulcers (2 cm in size), located in the postbulbar duodenum or small curvature of the stomach, 
active bleeding, the presence of comorbidities. All these factors require careful analysis and addi-
tional study in order to select the best method of surgical treatment. 
The aim of the research was to evaluate the effectiveness of X-ray interventions in arosive 
bleeding in patients with complicated duodenal ulcer.
2. Materials and methods of the research
The results of surgical treatment of complicated duodenal ulcer are presented according 
to the materials of the surgical department of the Kyiv Regional Clinical Hospital (base of the 
Department of Surgery and Proctology of the National Medical Academy of Postgraduate Educa-
tion named after P. L. Shupyk) published in 2018–2020.
X-ray endovascular intervention was used in the treatment of 8 patients with complicated 
duodenal ulcer who developed arosive bleeding. There were 6 men and 2 women. The mean age 




of patients was 54.2 ± 18.8 years (age range 34–74 years). Patients were taken to hospital within 
2 hours to 1 day with signs of gastrointestinal bleeding. All patients underwent standard labora-
tory methods (general clinical, biochemical, coagulation tests) and used instrumental diagnostic 
methods: FGDS, ultrasound of the abdominal cavity, spiral computed tomography (CT) with con-
trast enhancement (ultravist intravenous and triombrast 76 % orally).
For statistical analysis of the obtained results a package of general purpose data processing 
programs Statistica for Windows version 10.0 (Stat Soft inc., USA) was used. Evaluation of treat-
ment efficacy was performed taking into account the odds ratio (OR) of drugs, with the calculation 
of confidence intervals and the criterion of reliability and OR. At p < 0.05 discrepancies were con-
sidered statistically significant.
All patients received a full range of infusion and conservative therapy in the intensive care 
unit. In 6 (75 ± 4.5 %) patients bleeding was detected by blood per rectum. In 2 (25 ± 3.8 %) patients 
bleeding detected by nasogastric tube (Fig. 1) was accompanied by signs of gastrointestinal bleeding. 
In 2 (25 ± 1.7 %) patients bleeding occurred on the 2nd day after hemostatic therapy, in 6 pa-
tients (75 ± 6.1 %) – within the next 5–6 days. In 2 (25 ± 4.1 %) patients the bleeding was diffuse.
Fig. 1 Superselective catheterization of the pancreatic-duodenal artery.  
Extravasation of contrast into the lumen of the duodenum
During endovascular intervention, arterial access was performed from the right femoral artery 
according to Salinger under local anesthesia with 0.5 % solution of novocaine. Preliminary diagnostic 
angiography was performed with the inclusion of selective arteriography of the abdominal trunk and 
superior mesenteric artery with the obligatory obtaining of arterial, parenchymal and venous phases, 
followed by endovascular embolization of bleeding arteries, by introduction the embolizing spirals 
through arteries. The embolizing spirals are injected into both the afferent and excretory part of the 
vessel, and if possible also into the cavity of the false aneurysm, which is the cause of bleeding.
In addition, embolization of the bleeding artery is performed with a hemostatic sponge with 
calibrated synthetic emboli, which have a particle size of 1000–2000 microns.
Embolization of a false aneurysm is performed with a microcatheter, through which micro-
coils having a system of controlled electrical or mechanical separation from the catheter are su-
perselectively inserted into the cavity of the aneurysm and into the artery supplying it with pre-
cision. Such embolization is performed in case of inaccessibility of the lesion area with standard 
angiographic catheters (usually microcoils are used in interventional neuroradiology).
This method allows both the diagnosis of profuse duodenal hemorrhage from stenotic post-
bulbar ulcers and their subsequent controlled treatment by endovascular embolization while main-
taining organ function without recurrence of bleeding and achieving a rapid and reliable hemo-
static effect [19].
The method is implemented as follows.
First, a preliminary diagnostic angiography is performed, which includes selective arterio-
graphy of the abdominal trunk and superior mesenteric artery, with the obligatory obtaining of 
the arterial, parenchymal and venous phases.
 




The main sources of blood supply in this anatomical area are usually a. transcreaticoduo-
denalis superior (from the pool of a. gastroduodenalis, departing from a. hepatis communis) and 
a. pancreaticoduodenalis inferior (from the pool of a. mesenterica superior), which form an arterial 
arch and are interconnected by a network of anastomoses.
Characteristic angiographic symptoms of bleeding such as false aneurysms or temporary 
occlusions (thrombosis) of bleeding arteries are found in the projection of the hepatopancreatodu-
odenal area. In some cases, a symptom of contrast extravasation outside the bleeding artery (found 
in 10–20 % of cases with particularly severe profuse bleeding with a blood flow rate of more than 
0.5 cubic cm/min.) was detected [20].
After diagnosing the symptoms and establishing the cause of bleeding in patients, endovas-
cular embolization of bleeding arteries is performed (if technically possible, their superselective 
catheterization).
Embolization is performed by inserting metal coils of the Gianturco type with dimensions 
corresponding to the caliber of the occluded artery through a superselectively installed conven-
tional or hydrophilic angiographic catheter of the appropriate configuration (usually type «Sobra 
Visceral, «Selective Virseral», «Multipurpose»). These spirals are currently produced by several 
manufacturers and can have different configurations – cylindrical, spindle-shaped, hourglass type, 
spherical (3D), conical (type «Tornado»). Embolizing spirals are inserted into both the leading and 
diverting part of the vessel (to prevent recurrence of bleeding due to the restoration of retrograde 
blood flow to the area of vascular damage), and if possible the spiral is also inserted into the cavity 
of the false aneurysm to ensure its complete exclusion from blood flow. In some cases, in addition 
to trunk embolization of arteries with spirals, additional embolization with a hemostatic sponge 
and calibrated synthetic emboli, which have a particle size of 1000–2000 μm, is performed, which 
allows to achieve a faster and more reliable hemostatic effect. The use of smaller particles is unde-
sirable due to the risk of ischemic complications in the area of embolization.
If, in a patient with a false branch aneurysm a. mesenterica superior to reach the aneurysm 
cavity with a conventional angiographic catheter is technically impossible, and semi-selective em-
bolization can lead to intestinal necrosis due to emboli in the adjacent branches of the target artery, 
embolization of the defective aneurysm is performed by a microcatheter in which precision micro-
spirals are introduced, which have a system of electrically or mechanically controlled separation 
from the catheter (usually they are used in interventional neuroradiology). After the procedure, the 
catheter was removed from the arterial bed, a compression bandage was applied to the puncture 
site, and patients were adhered to a strict bed rest during the day, and received conservative therapy 
in the intensive care unit.
Example I. Patient /medical history N 27025/477/313/ was admitted to the surgical depart-
ment of CE KRC «Kyiv Regional Clinical Hospital» with a diagnosis of duodenal ulcer, subcom-
pensated pyloroduodenal stenosis, ulcer penetration, acute bleeding. Fibrogastroscopy revealed 
subcompensated pyloroduodenal stenosis, postbulbar ulcer, with a bleeding vessel. Due to the 
stable condition of the patient, the proposed method was used. Postoperative period was without 
complications. On the 10th day after surgery, the patient was discharged from the hospital in satis-
factory condition.
3. Results 
After stabilization, patients underwent endovascular intervention to prevent subse-
quent episodes of bleeding. Acute bleeding from the gastroduodenal artery was diagnosed in 
4 (50 ± 4.51 %) patients, acute bleeding from the pancreato-duodenal-intestinal artery was diag-
nosed in 2 (25 ± 3.8 %) patients and the source of bleeding is not detected in 2 (25 ± 4.1) %) patients. 
Respectively, 4 (50 ± 6.71 %) patients underwent gastroduodenal artery embolization (Fig. 2), 
2 (25 ± 3.95 %) patients underwent pancreatic – intestinal artery embolization and 2 (25 ± 2,91 %) 
of patients – embolization of the initial section of the common hepatic artery before the discharge 
of the pancreatic -duodenal-intestine artery.
In the near future, bleeding stopped in all 8 (100 %, OR–0.04 [0.005–0.29], p = 0.03) pa-
tients. On day 2, two (25 %) patients who underwent embolization of the common hepatic artery 




had a recurrence of bleeding (0.56 [0.065–4.76], p = 0.29). Repeated angiography and embolization 
attempts were ineffective. Laparotomy revealed that the bleeding was diffuse in nature, the source 
could not be localized, and those patients performed stitching of the most dubious areas of the duo-
denal mucosa. However, both patients died soon. In patients who underwent gastroduodenal artery 
embolization, bleeding did not resume. Thus, we obtained good results – 6 patients (75 %) survived 
out of 8, despite the severity of the condition and the disappointing prognosis (OR–9.0 [1.0–46.7], 
p < 0.05). The selective embolization of the gastroduodenal artery and superselective pancreatic- 
duodenal artery was the most effective, and there was no recurrence of bleeding at all.
Fig. 2. Endovascular embolization of a bleeding artery by introduction of embolizing metal 
spirals through a superselectively established angiographic catheter
Regarding the occurrence of ischemia of organs distal to embolization in our practice, we 
did not observe such complications, except for the appearance of hematomas in the femoral artery.
4. Discussion of research results
According to the literature, the source of bleeding is usually gastroduodenal, gastric 
source – duodenal, intestinal, left gastric, common or own hepatic artery, as well as the portal 
hepatic vein [21]. Bleeding due to a violation of the artery integrity may be in the duodenum, pan-
creatic duct, intra – or retroperitoneally. The first and second variants of bleeding are manifested 
in the form of a clinical picture of gastrointestinal bleeding, the third and fourth – the presence of 
blood in the drainage systems fixed earlier [22].
The literature provides various data on the development of recurrence of bleeding after 
embolization. The recurrence rate of bleeding in a study by F.Boudghene et al. was 37 % [23]. 
In contrast, H. Sethi and co-authors [24] did not observe any episodes of re-bleeding, all patients 
recovered. We found signs of re-bleeding in only 2 (25 %) patients who later died.
Open surgical treatment of arosive ulcerogenic (duodenal) bleeding is indicated in case of 
hemodynamic instability of the patient, unavailability of endovascular service or failure of attempt 
of X-ray vascular treatment. Surgical treatment for this type of bleeding is to suture the damaged 
vessel. H. Hyare and co-authors reported that the overall mortality in open surgical treatment of 
arosive pancreatogenic bleeding is 23 that equal 30 %, which is much higher than the correspond-
ing figure in the endovascular approach [25]. We believe that this statement is quite identical to 
duodenal bleeding. However, it is important to note that these authors performed laparotomy in 
hemodynamically unstable patients who already had bleeding, in contrast to the interventional 
approach in hemodynamically stable patients who are at high risk of bleeding according to instru-
mental methods, for example, did not consider the possibility of X-ray endovascular interventions 
to prevent bleeding.
5. Conclusions
1. If signs of gastrointestinal bleeding are detected in patients with complicated duode-
nal ulcer, it is recommended to perform fibrogastrodoudenoscopy, and perform CT angiography 
or direct selective angiography of the vessels of the abdominal cavity in order to exclude such 
 




a threatening complication of peritoneal arthritis as arosive bleeding from the peripancreatic (gas-
troduodenal) arteries.
2. If the presence of arosive bleeding is confirmed, emergency surgical treatment with su-
turing of the damaged vessel is shown in hemodynamically unstable patients, and endovascular 
intervention is possible in hemodynamically stable patients.
3. Further studies are needed to determine the criteria for a high risk of developing arosive 
bleeding in patients with complicated duodenal ulcer and to prevent its occurrence through the use 
of X-ray endovascular interventions.
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